Protection Against Cardiac Hypertrophy by Geniposide Involves the GLP-1 Receptor / AMPKα Signalling Pathway

British Journal of Pharmacology - United States
doi 10.1111/bph.13449
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Crocetin Protects Against Cardiac Hypertrophy by Blocking MEK-ERK1/2 Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2010English

Synergistic Effects of Metformin With Liraglutide Against Endothelial Dysfunction Through GLP-1 Receptor and PKA Signalling Pathway

Scientific Reports
Multidisciplinary
2017English

Bakuchiol Protects Against Pathological Cardiac Hypertrophy by Blocking NF Kappa B Signaling Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

Cardiac Hypertrophy and the WNT/Frizzled Pathway

Hypertension
Internal Medicine
2007English

Contribution of Brown Adipose Tissue Activity to the Control of Energy Balance by GLP-1 Receptor Signalling in Mice

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

The Nuclear Receptor RORα Protects Against Angiotensin II-induced Cardiac Hypertrophy and Heart Failure

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2019English

The Deubiquitinase UCHL1 Regulates Cardiac Hypertrophy by Stabilizing Epidermal Growth Factor Receptor

Science advances
Multidisciplinary
2020English

The Cardiovascular Effects of GLP-1 Receptor Agonists

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2010English

AKAP-Lbc Mobilizes a Cardiac Hypertrophy Signaling Pathway

Molecular Cell
Cell BiologyMolecular Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy